Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPEAL: Ciprofloxacin Prophylaxis for SWL
NCT03692715Phase 4Completed
- Sponsor
- Clinical Urology and Epidemiology Working Group
- Start
- Sep 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in urinary tract infection (UTI) comparing Ciprofloxacin with Placebo (2 arms). Primary endpoint: Composite outcome including positive urine culture, symptoms of cystitis, pyelonephritis or urosepsis. Started Sep 2018; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03692715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03692715.